Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
June in Review: iPhones interfere with cardiac devices | Think before you eat | Valve-in-valve TAVR outcomes
Wednesday, June 30, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

The Month in Review

Yes, Apple’s iPhone can interfere with implantable cardiac devices—here’s what you should know

This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.

READ MORE >
ECG rhythm strip from a 6-lead ECG
Share on Twitter Share on Facebook Share on Linkedin

Yes, Apple’s iPhone can interfere with implantable cardiac devices—here’s what you should know

Share on Twitter Share on Facebook Share on Linkedin
ECG rhythm strip from a 6-lead ECG
This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.
READ MORE >

Medtronic stops sales and distribution of HVAD system due to multiple issues, including 14 patient deaths

The device's internal pump was associated with a heightened risk of adverse outcomes, including stroke and death. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Medtronic stops sales and distribution of HVAD system due to multiple issues, including 14 patient deaths

Share on Twitter Share on Facebook Share on Linkedin
The device's internal pump was associated with a heightened risk of adverse outcomes, including stroke and death. 
READ MORE >

A massive physician shortage is coming—and it could hit cardiology especially hard

By 2034, the United States is expected to be short somewhere between 37,000 and 124,000 physicians.

READ MORE >
Doctor
Share on Twitter Share on Facebook Share on Linkedin

A massive physician shortage is coming—and it could hit cardiology especially hard

Share on Twitter Share on Facebook Share on Linkedin
Doctor
By 2034, the United States is expected to be short somewhere between 37,000 and 124,000 physicians.
READ MORE >

More than 200 lots of irbesartan, losartan and valsartan recalled in Canada

Nine different companies are included in the recall. 

READ MORE >
OhCanada
Share on Twitter Share on Facebook Share on Linkedin

More than 200 lots of irbesartan, losartan and valsartan recalled in Canada

Share on Twitter Share on Facebook Share on Linkedin
OhCanada
Nine different companies are included in the recall. 
READ MORE >

The top 10 hospitals for pediatric cardiology

Did your hospital make the list? 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

The top 10 hospitals for pediatric cardiology

Share on Twitter Share on Facebook Share on Linkedin
Did your hospital make the list? 
READ MORE >

New metric identifies heart failure patients facing a higher risk of hospitalization or death

This new measurement, researchers explained, can help clinicians target high-risk patients with more aggressive treatments. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New metric identifies heart failure patients facing a higher risk of hospitalization or death

Share on Twitter Share on Facebook Share on Linkedin
This new measurement, researchers explained, can help clinicians target high-risk patients with more aggressive treatments. 
READ MORE >

An encouraging update: Young adults with vaccine-related heart damage see all symptoms resolve

“Given the potential morbidity of COVID-19 infection even in younger adults, the risk-benefit decision for vaccination remains highly favorable," researchers wrote.

READ MORE >
vaccine
Share on Twitter Share on Facebook Share on Linkedin

An encouraging update: Young adults with vaccine-related heart damage see all symptoms resolve

Share on Twitter Share on Facebook Share on Linkedin
vaccine
“Given the potential morbidity of COVID-19 infection even in younger adults, the risk-benefit decision for vaccination remains highly favorable," researchers wrote.
READ MORE >

Think before you eat: How eating patterns in the US increase risk of cardiovascular disease, death

The study's authors examined data from more than 21,000 participants. 

READ MORE >
deli_sandwich_lunch_food.jpg
Share on Twitter Share on Facebook Share on Linkedin

Think before you eat: How eating patterns in the US increase risk of cardiovascular disease, death

Share on Twitter Share on Facebook Share on Linkedin
deli_sandwich_lunch_food.jpg
The study's authors examined data from more than 21,000 participants. 
READ MORE >

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Share on Twitter Share on Facebook Share on Linkedin
Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.
READ MORE >

FDA approves first oral blood thinner for pediatric patients

The approval includes patients as young as three months old. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first oral blood thinner for pediatric patients

Share on Twitter Share on Facebook Share on Linkedin
The approval includes patients as young as three months old. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme